Advances in Proximal Occlusion Devices for Carotid Angioplasty and Stenting

Original title: A Meta-Analysis of Proximal Oclusion Device Outcome in Carotid Artery Stenting Reference: Robert M Bersin, et al. Catheterization and Cardiovascular Intervention 80:1072-78 (2012)

Carotid Angioplasty and Stenting (CAS) is considered a valid alternative to treat high risk patients. Embolic protection devices have been proved effective and currently there are two EPDs available: proximal occlusion and distal occlusion devices. 

The goal of this meta-analysis was to determine risk predictors of adverse events in carotid stenting using proximal occlusion devices. 2397 patients were submitted to CAS with Mo.MA or Gore Flow Reversal System. End point was a composite of death, infarction and stroke at 30 days. Mean age was 70, 37% were diabetic and 31% were symptomatic.

The composite primary endpoint at 30 days was 2.25%.The incidence of stroke was 1.71%. The incidence of myocardial infarction was 0.02%. The incidence of death was 0.40%. The presence of contralateral occlusion was not found to predict intolerance, however a

Multivariate analysis showed that age and diabetic status were found to be the only significant independent risk predictors. A significant difference was observed in risk of stroke according to age, with a 1% chance in

Conclusion 

This meta-analysis of CAS using proximal EPDs presented a low rate of complications at 30 days; age and diabetics were the best risk predictors.

Editorial Comment:

This study is a meta-analysis that collected data from trials that studied only one branch, performed by experienced operators in good candidates. The resulting good outcomes (especially taking into account the number of diabetic and symptomatic patients) may be the best ever. This is an important limitation to this study. The important number of patients analyzed helps us have an idea of evolution at 30 days with these devices that, although quite different, act similarly and may have an advantage, at least in theory, over filters.

It would be interesting to see further controlled research comparing both devices to determine the best option, or which of them best adequate to every case in particular.

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...